Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Colorectal Cancer

Clinical Oncology

Volumn 24, Issue 4, 2012, Pages 232-249

  Chan, K ^a   Welch, S ^b   Walker Dilks, C ^c   Raifu, A ^c  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Colorectal cancer; Diagnosis; FDG PET; Liver metastases; Recurrence; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; GASTROINTESTINAL RADIOGRAPHY; HUMAN; LIVER METASTASIS; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

COLORECTAL NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84858795206     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.11.008     Document Type: Article

References (37)

1. Canadian cancer statistics 2010, Canadian Cancer Society/National Cancer Institute of Canada, 2010, CCS/NCIC, Toronto.
2. Facey K., Bradbury I., Laking G., Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 2007, 11(44). iii-iv, xi-267.
3. Sheehan J.J., Ridge C.A., Ward E.V., et al. FDG PET in preoperative assessment of colorectal liver metastases combining " evidence-based practice" and " technology assessment" methods to develop departmental imaging protocols: should FDG PET be routinely used in the preoperative assessment of parents with colorectal liver metastases?. Acad Radiol 2007, 14:389-397.
4. Bipat S., van Leeuwen M.S., IJzermans J.N., et al. Evidence-based guideline on management of colorectal metastases in the Netherlands. Neth J Med 2007, 65(1):5-14.
5. Bipat S., van Leeuwen M.S., Comans E.F., et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 2005, 237:123-131.
6. Watson A.J., Lolohea S., Robertson G.M., Frizelle F.A. The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 2006, 50:102-114.
7. Podoloff D.A., Advani R.H., Allred C., et al. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 2007, 5(Suppl. 1):S1-S22. quiz S23-22.
8. Zhang C., Chen Y., Xue H., et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 2009, 124:167-173.
9. Vriens D., de Geus-Oei L.F., van der Graaf W.T., Oyen W.J. Tailoring therapy in colorectal cancer by PET-CT. Q J Nucl Med Mol Imaging 2009, 53(2):224-244.
10. Furukawa H., Ikuma H., Seki A., et al. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Gut 2006, 55(7):1007-1011.
11. Nahas C.S., Akhurst T., Yeung H., et al. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation. Ann Surg Oncol 2008, 15(3):704-711. Erratum in: Ann Surg Oncol 2008;15(4):1265.
12. Kosugi C., Saito N., Murakami K., et al. Positron emission tomography for preoperative staging in patients with locally advanced or metastatic colorectal adenocarcinoma in lymph node metastasis. Hepato-Gastroenterology 2008, 55(82-83):398-402.
13. Llamas-Elvira J.M., Rodríguez-Fernández A., Gutiérrez-Sáinz J., et al. Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging 2007, 34(6):859-867.
14. Park I.J., Kim H.C., Yu C.S., et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol 2006, 32(9):941-947.
15. Tsunoda Y., Ito M., Fujii H., Kuwano H., Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol 2008, 38(5):347-353.
16. Veit-Haibach P., Kuehle C.A., Beyer T., et al. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. JAMA 2006, 296(21):2590-2600.
17. Kinner S., Antoch G., Bockisch A., Veit-Haibach P. Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging. Abdom Imaging 2007, 32(5):606-612.
18. Orlacchio A., Schillaci O., Fusco N., et al. Role of PET/CT in the detection of liver metastases from colorectal cancer. Radiologia Medica 2009, 114(4):571-585.
19. Bystrom P., Berglund A., Garske U., et al. Early prediction of response to first-line chemotherapy by sequential[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer. Ann Oncol 2009, 20(6):1057-1061.
20. Capirci C., Rubello D., Chierichetti F., et al. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. AJR Am J Roentgenol 2006, 187(2):W202-W208.
21. Kalff V., Duong C., Drummond E.G., Matthews J.P., Hicks R.J. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 2006, 47(1):14-22.
22. Cascini G.L., Avallone A., Delrio P., et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006, 47(8):1241-1248.
23. Glazer E.S., Beaty K., Abdalla E.K., et al. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases. Arch Surg 2010, 145(4):340-345.
24. Capirci C., Rampin L., Erba P.A., et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007, 34(10):1583-1593.
25. Kristiansen C., Loft A., Berthelsen A.K., et al. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum 2008, 51(1):21-25.
26. Sobhani I., Tiret E., Lebtahi R., et al. Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 2008, 98(5):875-880.
27. Ruers T.J.M., Wiering B., van der Sijp J.R.M., et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with 18F-FDG PET: a randomized study. J Nucl Med 2009, 50(7):1036-1041.
28. Rappeport E.D., Loft A., Berthelsen A.K., et al. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 2007, 48(4):369-378.
29. Huguet E.L., Old S., Praseedom R.K., Balan K.K., Gibbs P., Jamieson N.V. F18-FDG-PET evaluation of patients for resection of colorectal liver metastases. Hepatogastroenterology 2007, 54(78):1667-1671.
30. Liu Y., Huang M., An Q., Wei J. The impact of PET/CT on therapeutic strategy of patients with colorectal cancer metastasis. Hepato-Gastroenterology 2009, 56(93):968-970.
31. Kitajima K., Murakami K., Yamasaki E., et al. Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging 2009, 36(9):1388-1396.
32. Potter K.C., Husband J.E., Houghton S.L., Brown G. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 2009, 52(72):253-259.
33. Adie S., Yip C., Chu F., et al. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?. ANZ J Surg 2009, 79(5):358-361.
34. Lubezky N., Metser U., Geva R., et al. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 2007, 11(4):472-478.
35. Denecke T., Steffen I., Hildebrandt B., et al. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease. Acta Radiol 2007, 48(8):821-830.
36. Wiering B., Ruers T.J., Krabbe P.F., Dekker H.M., Oyen W.J. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Ann Surg Oncol 2007, 14(2):818-826.
37. Sarikaya I., Povoski S.P., Al-Saif O.H., et al. Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer. World J Surg Oncol 2007, 16(5):80.